Citigroup Inc Harmony Biosciences Holdings, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Citigroup Inc holds 178,076 shares of HRMY stock, worth $6.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,076

Previous 182,049 2.18%

Holding current value

$6.06 Million

Previous $5.75 Million 14.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$26.76 - $38.05 $106,317 - $151,172	-3,973 Reduced 2.18%	178,076 $4.91 Million
Q2 2025 Aug 11, 2025	SELL	$27.94 - $35.91 $650,750 - $836,379	-23,291 Reduced 11.34%	182,049 $5.75 Million
Q1 2025 May 12, 2025	BUY	$32.18 - $40.46 $178,245 - $224,107	5,539 Added 2.77%	205,340 $6.82 Million
Q4 2024 Feb 12, 2025	BUY	$31.86 - $41.49 $699,581 - $911,037	21,958 Added 12.35%	199,801 $6.88 Million
Q3 2024 Nov 12, 2024	BUY	$30.0 - $39.95 $475,770 - $633,567	15,859 Added 9.79%	177,843 $7.1 Million

Q2 2024 Aug 12, 2024	SELL	$28.81 - $33.01 $44,540 - $51,033	-1,546 Reduced 0.95%	161,984 $4.89 Million
Q1 2024 May 10, 2024	SELL	$29.93 - $35.06 $104,425 - $122,324	-3,489 Reduced 2.09%	163,530 $5.49 Million
Q4 2023 Feb 09, 2024	BUY	$19.2 - $33.78 $2.74 Million - $4.81 Million	142,537 Added 582.21%	167,019 $5.39 Million
Q3 2023 Nov 09, 2023	SELL	$31.89 - $39.03 $260,445 - $318,758	-8,167 Reduced 25.01%	24,482 $802,000
Q2 2023 Aug 10, 2023	BUY	$30.5 - $37.4 $326,441 - $400,292	10,703 Added 48.77%	32,649 $1.15 Million
Q1 2023 May 11, 2023	SELL	$30.8 - $53.92 $197,582 - $345,896	-6,415 Reduced 22.62%	21,946 $716,000
Q4 2022 Feb 09, 2023	BUY	$45.4 - $60.91 $96,520 - $129,494	2,126 Added 8.1%	28,361 $1.56 Million
Q3 2022 Nov 10, 2022	BUY	$42.06 - $55.45 $250,887 - $330,759	5,965 Added 29.43%	26,235 $1.16 Million
Q2 2022 Aug 10, 2022	SELL	$33.54 - $52.15 $164,413 - $255,639	-4,902 Reduced 19.47%	20,270 $989,000
Q1 2022 May 12, 2022	BUY	$33.14 - $51.13 $133,554 - $206,053	4,030 Added 19.06%	25,172 $1.23 Million
Q4 2021 Feb 10, 2022	BUY	$34.09 - $43.91 $620,812 - $799,645	18,211 Added 621.32%	21,142 $901,000
Q3 2021 Nov 10, 2021	BUY	$25.68 - $38.61 $75,268 - $113,165	2,931 New	2,931 $112,000

Others Institutions Holding HRMY

# of Institutions

317

Shares Held

42.8M

Call Options Held

1.05M

Put Options Held

310K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.01B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account